Company / Cash & Equivalents
Cardinal Health Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$3.9B
FY2025
5-year range
$2.8B / $5.1B
FY2021-FY2025
Trend
-24.5%
vs FY2024
Sector context
#14 of 148
Health Care
What the data says
Among 148 Health Care companies, Cardinal Health is in the top 9% for cash & equivalents. Cash & Equivalents has fluctuated over the past 10 years, ranging from $1.8B in FY2020 to $6.9B in FY2019.
Based on SEC 10-K filings.
$3.9B in FY2025 with a 5-year CAGR of +17.1%. Top quartile in the Health Care sector.
Declined from $4.1B to $3.9B over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -6.4%
- 5-Year CAGR
- +17.1%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 148This company $3.9B Sector average $1.2B
▼
+229.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +17.1%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 24.5% year-over-year.
- Ranks #14 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 4.27 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.9B | -24.5% |
| FY2024 | $5.1B | +25.9% |
| FY2023 | $4.1B | -13.6% |
| FY2022 | $4.7B | +70.2% |
| FY2021 | $2.8B | +57.2% |
| FY2020 | $1.8B | -74.4% |
| FY2019 | $6.9B | +290.2% |
| FY2018 | $1.8B | -61.8% |
| FY2017 | $4.6B | +61.1% |
| FY2016 | $2.9B | -37.9% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026